Bruce Robert Blazar MD
Regents Professor, Pediatrics, University of Minnesota Medical School
Join to View Full Profile
516 Delaware Street SEUniversity of MN Physicians PWB Fifth floor Clinic 5BMinneapolis, MN 55455
Phone+1 612-273-2800
Fax+1 612-626-4074
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Bruce Blazar, MD is a pediatric hematologist/oncologist in Minneapolis, Minnesota. He is currently licensed to practice medicine in Minnesota. He is a Regents Professor at University of Minnesota Medical School.
Education & Training
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1982 - 1985- University of MinnesotaResidency, Pediatrics, 1978 - 1981
Albany Medical CollegeClass of 1978
Certifications & Licensure
MN State Medical License 1980 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 1 citationsTargeting cell-surface VISTA expression on allospecific naïve T cells promotes tolerance.Brent H Koehn, Elizabeth C Nowak, Sladjana Skopelja-Gardner, Asim Saha, Michael C Zaiken
Blood. 2025-04-10 - Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease.Julie R Boiko, Kathleen S Ensbey, Olivia G Waltner, Isaac C Jenkins, Shruti S Bhise
Blood. 2025-02-20 - Activation-induced thrombospondin-4 works with thrombospondin-1 to build cytotoxic supramolecular attack particles.Chiara Cassioli, Nagaja Capitani, Claire C Staton, Claudia Schirra, Francesca Finetti
Proceedings of the National Academy of Sciences of the United States of America. 2025-02-11
Press Mentions
CARISMA Therapeutics Establishes Collaboration with Leading Cell Therapy Expert to Explore and Develop Allogeneic CAR-MacrophagesApril 26th, 2021- Magenta Therapeutics Announces Multiple Presentations Across Stem Cell Transplant Portfolio at the American Society of Hematology (ASH) Annual MeetingNovember 4th, 2020
BlueRock Therapeutics Establishes Key Partnerships with Leading Experts in Autoimmune DiseaseJanuary 16th, 2019- Join now to see all
Grant Support
- University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UNIVERSITY OF MINNESOTA2023–2030
- University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UNIVERSITY OF MINNESOTA2023–2030
- University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UNIVERSITY OF MINNESOTA2023–2030
- University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UNIVERSITY OF MINNESOTA2023–2030
- In Vivo Prevention of Murine GVHDUNIVERSITY OF MINNESOTA2022–2027
- In Vivo Prevention of Murine GVHDUNIVERSITY OF MINNESOTA2022–2027
- In Vivo Prevention of Murine GVHDUNIVERSITY OF MINNESOTA2022–2027
- Enhancing Treg Therapeutic Efficacy in GVHDUNIVERSITY OF MINNESOTA2014–2026
- Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory DiseaseUNIVERSITY OF MINNESOTA2021–2025
